STOCK TITAN

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) Financials

FCRX
FY2025 annual
Revenue Not reported for FY2025
Net Income $34.5M -53.1% YoY
EPS (Diluted) $1.81 YoY not available
Operating Cash Flow $74.7M +26.8% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FCRX SEC filings page.

This page shows Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Crescent Capital BDC, Inc. 5.00% Notes due 2026 does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
4/6

Crescent Capital BDC, Inc. 5.00% Notes due 2026 passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Cash-Backed
2.17x

For every $1 of reported earnings, Crescent Capital BDC, Inc. 5.00% Notes due 2026 generates $2.17 in operating cash flow ($74.7M OCF vs $34.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
N/A

Crescent Capital BDC, Inc. 5.00% Notes due 2026 reported an operating loss of $98.7M against $57.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$15.5M
YoY-497.4%

Crescent Capital BDC, Inc. 5.00% Notes due 2026 reported -$15.5M in net income in Q1 2026. This represents a decrease of 497.4% from the same quarter a year earlier.

EPS (Diluted)
$0.42
YoY-6.7%

Crescent Capital BDC, Inc. 5.00% Notes due 2026 earned $0.42 per diluted share (EPS) in Q1 2026. This represents a decrease of 6.7% from the same quarter a year earlier.

Revenue

Not reported for Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt
$6.1M
YoY-49.0%
QoQ+21.7%

Crescent Capital BDC, Inc. 5.00% Notes due 2026 held $6.1M in cash against $907.1M in long-term debt as of Q1 2026.

Shares Outstanding
37M
YoY-0.4%
QoQ-0.1%

Crescent Capital BDC, Inc. 5.00% Notes due 2026 had 37M shares outstanding in Q1 2026. This represents a decrease of 0.4% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Return on Equity
-2.3%
YoY-2.8pp

Crescent Capital BDC, Inc. 5.00% Notes due 2026's ROE was -2.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 2.8 percentage points from the same quarter a year earlier.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Net Margin

Not reported for Q1 2026.

Capital Allocation

Share Buybacks
$1.0M
QoQ0.0%

Crescent Capital BDC, Inc. 5.00% Notes due 2026 spent $1.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. It is unchanged from the prior quarter.

R&D Spending

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

FCRX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCRX quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'25Q1'2510-QQ4'2410-KQ3'2410-QQ2'24
Operating Income-$21.9M+12.6%N/A-$24.1M+12.0%-$25.7M+4.1%-$25.0M+6.3%N/A-$27.4M-5.2%-$26.8M-3.8%
Interest Expense$13.7M-6.1%N/A$13.9M-13.8%$15.2M-4.9%$14.6M-6.2%N/A$16.1M+4.7%$15.9M+4.3%
Income TaxN/AN/A$0-100.0%$0$6KN/A$155K$0
Net Income-$15.5M-497.4%N/A$7.1M-53.5%$15.0M-26.4%$3.9M-86.1%N/A$15.3M-32.5%$20.4M-9.7%
EPS (Basic)$0.42-6.7%N/A$0.46-28.1%$0.46-22.0%$0.45-28.6%N/A$0.64+8.5%$0.59+5.4%
EPS (Diluted)$0.42-6.7%N/A$0.46$0.46-22.0%$0.45N/A$0.64$0.59+5.4%
Diluted Shares (Avg)37M-0.4%N/A37M37M0.0%37MN/A37M37M0.0%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA.

FCRX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCRX quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'25Q1'2510-QQ4'2410-KQ3'2410-QQ2'24
Total Assets$1.6B-2.9%$1.6B-2.1%$1.6B-1.1%$1.7B-1.1%$1.7B+2.8%$1.7B+1.8%$1.6B+1.3%$1.7B+2.9%
Cash & Equivalents$6.1M-49.0%$5.0M-50.2%$5.8M-66.1%$9.7M-11.6%$12.0M+78.5%$10.1M+30.2%$17.1M+184.8%$11.0M+46.2%
Total Liabilities$943.6M+0.5%$916.1M+0.1%$913.6M+1.9%$929.7M+1.1%$939.4M+8.1%$915.6M+3.5%$896.2M+0.2%$920.0M+2.4%
Long-Term Debt$907.1M+0.5%$873.8M-0.2%$875.3M+2.1%$887.3M+0.8%$903.0M+8.6%$875.8M+3.7%$857.2M+0.1%$879.9M+2.4%
Total Equity$674.0M-7.3%$706.0M-4.7%$714.1M-4.6%$724.7M-3.7%$727.1M-3.3%$740.6M-0.3%$748.8M+2.5%$752.4M+3.7%
Retained Earnings-$282.0M-21.6%-$251.0M-14.9%-$244.7M-12.7%-$234.4M-9.8%-$232.0M-8.3%-$218.5M+2.2%-$217.1M-273.9%-$213.5M-241.4%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

FCRX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCRX quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'25Q1'2510-QQ4'2410-KQ3'2410-QQ2'24
Operating Cash Flow-$23.8M-57.3%$22.6M+883.9%$30.8M-34.4%$36.4M+247.9%-$15.1M-138.3%-$2.9M-108.3%$46.9M+119.8%-$24.6M-221.1%
Financing Cash Flow$18.8M+195.6%-$18.9M-480.6%-$29.1M+35.8%-$40.9M-242.2%$6.3M+119.9%$5.0M+115.1%-$45.3M-125.9%$28.8M+186.2%
Dividends Paid$15.5M-10.9%$15.6M-14.3%$17.4M-7.9%$17.4M-9.6%$17.4M-7.8%$18.2M-2.0%$18.9M+4.1%$19.3M+26.8%
Share Buybacks$1.0M$1.0MN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow.

FCRX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FCRX quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'25Q1'2510-QQ4'2410-KQ3'2410-QQ2'24
Return on Equity-2.3%-2.8ppN/A1.0%-1.1pp2.1%-0.6pp0.5%-3.2ppN/A2.0%-1.1pp2.7%-0.4pp
Return on Assets-1.0%-1.2ppN/A0.4%-0.5pp0.9%-0.3pp0.2%-1.5ppN/A0.9%-0.5pp1.2%-0.2pp
Debt-to-Equity1.35+0.1x1.24+0.1x1.23+0.1x1.22+0.1x1.24+0.1x1.180.0x1.140.0x1.170.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Frequently Asked Questions

Is Crescent Capital BDC, Inc. 5.00% Notes due 2026 profitable?

Yes, Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) reported a net income of $34.5M in fiscal year 2025.

What is Crescent Capital BDC, Inc. 5.00% Notes due 2026's earnings per share (EPS)?

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) reported diluted earnings per share of $1.81 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Crescent Capital BDC, Inc. 5.00% Notes due 2026 have?

As of fiscal year 2025, Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) had $5.0M in cash and equivalents against $873.8M in long-term debt.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) generated $74.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) had $1.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) had 37M shares outstanding as of fiscal year 2025.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) had a debt-to-equity ratio of 1.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) reported an operating loss of $98.7M against $57.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top